Stay updated on Galcanezumab for Vestibular Migraine Clinical Trial
Sign up to get notified when there's something new on the Galcanezumab for Vestibular Migraine Clinical Trial page.

Latest updates to the Galcanezumab for Vestibular Migraine Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry labeled v3.5.4 has been added to the study record history, indicating an updated version of the record. This update appears to reflect metadata changes rather than modifications to study results or details.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe update changes the displayed ClinicalTrials.gov interface revision version from v3.5.2 to v3.5.3, reflecting a minor site release rather than any modification to the trial record itself.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No visible changes to study data or page content.SummaryDifference0.1%

- Check58 days agoChange DetectedA new revision v3.5.0 is added to the record history, and revision v3.4.3 is removed.SummaryDifference0.1%

- Check65 days agoChange DetectedNew revision tag v3.4.3 was added to the page history and the previous tag v3.4.2 was removed.SummaryDifference0.1%

- Check94 days agoChange DetectedA new revision entry (v3.4.2) was added to the study history. The deletions include a site-wide funding notice and the previous revision (v3.4.1).SummaryDifference0.8%

Stay in the know with updates to Galcanezumab for Vestibular Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galcanezumab for Vestibular Migraine Clinical Trial page.